Transcranial pulsed electromagnetic fields for treatment-resistant depression: A multicenter 8-week single-arm cohort study.

CONCLUSIONS.: The findings indicate a potential beneficial role of T-PEMF therapy as an augmentation treatment to ongoing pharmacotherapy in treatment-resistant depression. PMID: 32093804 [PubMed - in process]
Source: Journal of the Association of European Psychiatrists - Category: Psychiatry Tags: Eur Psychiatry Source Type: research

Related Links:

This study assess...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news
Abstract BACKGROUND: Reducing the length of hospital stay (lohs) of elderly psychiatric patients is of great importance. The role of electroconvulsive therapy (ect) in this process is still unclear. AIM: To explore the impact of ect on the lohs in elderly (>60 years) with major depressive disorder (mdd). METHOD: All charts of patients with a diagnosis of mdd, discharged from geriatric psychiatry wards from April 2009 to December 2017 were gathered. Two groups were further explored: those who did not receive ect although available (no-ect; n = 170) and those who received ect within 3 weeks of admission (ect
Source: Tijdschrift voor Psychiatrie - Category: Psychiatry Authors: Tags: Tijdschr Psychiatr Source Type: research
Psychotic depression (PD) is a severe disorder that may be more common among the older vs. younger adults. The significant morbidity and disability associated with acute episodes of PD can be especially prominent in the elderly. Treatment guidelines recommend either electroconvulsive therapy or the combination of antidepressant and antipsychotic medications for the acute treatment of PD. However, little is known about the risks and benefits of antipsychotic medication during continuation and maintenance treatment.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Session 413 Source Type: research
Abstract: Electroconvulsive therapy (ECT) is an increasingly popular treatment for drug-resistant depression that may have utility for some patients with neuroleptic malignant syndrome (NMS) who are unresponsive to pharmacotherapy. Using a case study as an example, this article discusses the diagnosis of a patient with NMS, the use of ECT as a treatment for NMS, and the importance of nursing care for these patients.
Source: Nursing - Category: Nursing Tags: Feature: CE Connection Source Type: research
Brief education using videos or brochures improves patients ’ understanding and willingness to consider electroconvulsive therapy (ECT), suggests astudy inPsychiatric Services in Advance.“ECT remains a maligned, underutilized treatment, and psychoeducation may be important in improving access to those who may beneļ¬t from it,” wrote Jack Tsai, Ph.D., of Yale School of Medicine and colleagues.The researchers randomly assigned 556 adults who screened positive for depression on the Patient Health Questionnaire-9 to one of two education groups. One group watched an eight-minute video about ECT and the other ...
Source: Psychiatr News - Category: Psychiatry Tags: depression ECT education electroconvulsive therapy Jack Tsai Psychiatric Services in Advance Source Type: research
R, Benseñor I, Valiengo L, Brunoni AR Abstract Current first-line treatments for major depressive disorder (MDD) include pharmacotherapy and cognitive-behavioral therapy. However, one-third of depressed patients do not achieve remission after multiple medication trials, and psychotherapy can be costly and time-consuming. Although non-implantable neuromodulation (NIN) techniques such as transcranial magnetic stimulation, transcranial direct current stimulation, electroconvulsive therapy, and magnetic seizure therapy are gaining momentum for treating MDD, the efficacy of non-convulsive techniques is still mod...
Source: Revista Brasileira de Psiquiatria - Category: Psychiatry Authors: Tags: Braz J Psychiatry Source Type: research
Somatoform disorders occur in up to 13% of those over age 65 and symptoms often cause significant impairment and disability (Hilderink et al. 2013; Leong et al. 2015). Unintentional weight loss in the elderly is also common and associated with increased morbidity and mortality (Hajek et al. 2017; McMinn et al. 2011). Studies show that depression is often comorbid with both somatoform disorders and unintentional weight loss in the elderly (Leong et al. 2015; Thompson and Morris 1991). Electroconvulsive therapy (ECT) is an effective treatment for severe depression, especially in older adults.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Poster Number: EI-2 Source Type: research
Psychotic depression (PD) is a severe disorder that may be more common among the older vs. younger adults. The significant morbidity and disability associated with acute episodes of PD can be especially prominent in the elderly. Treatment guidelines recommend either electroconvulsive therapy or the combination of antidepressant and antipsychotic medications for the acute treatment of PD. However, little is known about the risks and benefits of antipsychotic medication during continuation and maintenance treatment.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: SUSTAINING REMISSION OF PSYCHOTIC DEPRESSION: THE STOP-PD II STUDY TREATMENT RISKS AND BENEFITS IN LATE LIFE Source Type: research
• Electroconvulsive therapy (ECT) has been clinically proven to be an effective form of treatment for severe depression. It is also a safe treatment option when a quick response is needed. ECT is especially useful in the geriatric population where the complications of severe depression like not ea ting or drinking, self-neglect, deteriorating medical co morbidities lead to increased morbidity and mortality. •Several studies have compared efficacy of the different electrode placements as well as any resulting cognitive side effects from ECT.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Poster Number: EI-54 Source Type: research
Over 5.8?million people in the US are currently living with Alzheimer's disease (AD), the most common form of neurodegenerative dementia. More than 90% of individuals with AD experience neuropsychiatric symptoms (NPS), such as agitation, apathy, and depression. Agitation is one of the most common NPS, which not only accounts for 12% of health and social care costs but also increases the risk of mortality and caregiver burden. The most common treatments for agitation include psychotropic medications, used off-label, along with behavioral management strategies.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Poster Number: NR - 29 Source Type: research
More News: Denmark Health | Depression | Electroconvulsive Therapy | Psychiatry | Study | Women